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GABA and Dopamine Act Directly 
on Melanotropes of Xenopus 
to Inhibit MSH Secretion1 
B. M. L. VERBURG-VAN KEMENADE, B. G. JENKS 
AND A. G. J. DRIESSEN 
Department of Zoology, Faculty of Science, Catholic University 
Toernooiveld, 6525 ED Nijmegen, The Netherlands 
VERBURG-VAN KEMENADE, B. M. L., B. G. JENKS AND A. G. J. DRIESSEN. GABA anddopamine act directly on 
melano~ropes ofxenopus to inhibit MSH secretion. BRAIN RES BULL 17(5) 697-704, 1986.-The release of mebmophore 
stimulating hormone (MSH) from the pars intermedia of the amphibian Xenopus laevis is regulated by multiple factors of 
hypothalamic origin. The aim of this study was to determine if potential secretagogues function through a direct action on 
the melanotrope cell. For this purpose an in vitro superfusion system containing isolated melanotropes (cell suspension) 
was utilized. The viability of the cells in suspension was tested by examining their ability to synthesize, process and release 
pro-opiomelanocortin (POMC) related peptides. All biosynthetic functions appeared normal, with the exception that the 
isolated melanotropes are unable to N-terminally acetylate MSH. Release of immunoreactive-MSH fi-om these celjs was 
shown to be Ca*+-dependent, and high K+ stimulated release. Both the neurotransmitters dopamine and y-aminobutyric 
acid (GABA), which are thought to be physiologically important MSH-release inhibiting factors, were shown to inhibit 
MSH release from isolated melanotropes. Dopamine appeared to function through a dopamine D2 type receptor mech- 
anism while for GABA, both a GABAa and GABAb receptor mechanism are involved. 
Melanotropes Melanophore stimulating hormone 
Pro-opiomelanocortin Amphibian Dopamine 
aMSH 
GABA 
Desacetyl-arMSH Acetylation 
Receptor characterization 
THE regulation of dispersion of the black pigment melanin in 
dermal melanophores of amphibians is an example of a 
neuroendocrine reflex [ 11. Most amphibians, when placed on 
a black background, release melanophore stimulating hor- 
mone (MSH) from the pars intermedia of the pituitary gland 
and consequently there is a darkening of the skin. While it is 
thought hat central integration of the environmental input 
(color of background) would play an important role in de- 
termining the ‘rate of MSH secretion, a consideration of the 
complexity of the innervation of the pars intermediate lobe 
itself may be an important factor in this integration. For 
example, in the aquatic toad Xenopus laevis, a dopaminergic 
system [24,25], an adrenergic system [9] and a GABAergic 
system [29] have been described within the pars intermedia. 
Moreover it has been shown that both dopamine [ 10,141 and 
a-adrenergic receptor agonists [28] as well as GABA [29] 
inhibit MSH release from incubated neurointermediate lobes 
of this species. In studies with intact neurointermediate lobe 
tissue the question arises if the secretagogues affect MSH 
release through an action directly on the melanotrope cells. 
The alternative is an indirect action, such as GABA induced 
release of dopamine, a phenomenon known to occur in the 
central nervous system [23]. To determine to what extent he 
pars intermedia melanotrope cell might be involved in inte- 
grating signals from the diverse neuronal systems within the 
neurointermediate lobe tissue, we are em the effects 
of secretagogues on the release of immunoreactive MSH 
from isolated superfused melanotrope cells. The present 
study describes our preparation of melanotrope cell suspen- 
sion and shows that both dopamine and GABA act directly 
on these cells. 
METHOD 
Animals 
Xenopus laevis were bred and reared in our aquatic 
facility. Prior to the experiment the animals were kept for 
four weeks on a black background under constant illumina- 
tion at 22°C. 
Preparation of Cell Suspension 
Neurointermediate lobes were extirpated, rinsed in incu- 
bation medium (IM) containing 112 mM NaCl, 2 mM KCl, 2 
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FIG. 1. Comparison of viability of neurointermediate lobes and isolated intermediate 
lobe melanotropes ofxenopus laevis. Both intact tissue and cell suspension were given 
a I hr pulse-incubation in [sH]lysine followed by a 3 hr chase incubation in medium 
containing L-lysine. Tissue extract, cell extract and chase incubation media were 
submitted to HPLC. The elution gradient (% secondary solvent, B) is given. Charac- 
terization of the newly synthesized peptides (numbered I-VIII) has been reported 
earlier [19] and is summarized in the Results section. Arrows indicate a major differ- 
ence between intact tissue and cell suspension, namely the relatively high contribution 
of product II to the incubation medium of the cell suspension. This product has been 
previously identified as desacetyl-oMSH. 
mM CaQ.2 H,O, 2 mg/ml glucose, 15 mM Hepes pH 7.38. 
The medium was preaerated with carbogen. The tissue was 
subsequently transferred to 1.5 ml IM to which was added 3 
mg/ml bovine serum albumin (BSA, Sigma Fraction V), 1 
mg/ml collagenase (Sigma) and 1.25 mg/ml dispase (grade II 
lyophilisat, Boehringer) and incubated for 1 hr in a shaking 
water bath at 22°C. After centrifugation (10 min, 200 g, 22°C) 
the pellet was carefully suspended in 1.5 ml Ca-free medium 
to which 3 mg/ml BSA and 0.4 mg/ml ETDA were added. 
The suspension was centrifuged, resuspended in 1.5 ml Ca- 
free medium with 3 mg/ml BSA and 1.25 mg/ml dispase and 
incubated for 30 min at 22°C with shaking. Tissue fragments 
were then allowed to settle and the supematant containing 
melanotropes in suspension (fraction 1) was saved. The 
fragments were rinsed and treated with Ca-free medium con- 
taining BSA and dispase, and centrifuged for 3 min at 200 g 
over a nylon filter (pore size 0.15 mm). The collected cell 
suspension (fraction 2) was combined with fraction 1 and 
centrifuged (10 min, 200 g). The pellet was rinsed and resus- 
pended first in medium containing 3 mg/ml BSA, 0.8 mg/ml 
EDTA. Finally it was centrifuged and suspended in IM with 
0.3 mg/ml BSA. All glassware was siliconized. 
The percentage of cell death was established with trypan 
blue and cell yield was estimated with a haemocytometer. 
Pars nervosa remnants were traced by cytochemical staining 
with anti-oxytocin. 
Pulse-Chase Incubation of Neurointermediate Lobe Tissue 
or Isolated Melanotropes 
Neurointermediate lobe tissue was extirpated, rinsed in 
IM and given a pulse incubation in 200 ~1 IM containing 40 
&i [WIlysine (75 Wmmol, Amersham), on a shaking 
water bath at 22°C. Tissue was rinsed in IM and chase incu- 
bated in 200 ~1 medium containing L-lysine (2 mM). It was 
then homogenized in 500 ~1 ice-cold 0.1 N HCl in a glass 
homogenizer and centrifuged (10 min, 10,800 g, 4°C). The 
supematant was stored at -20°C before it was submitted to 
high performance liquid chromatography (HPLC) for sep- 
aration of peptides. The incubation medium was acidified 
with 20 ~1 1 N HCl and kept at -20°C before chromatography. 
For pulse-chase analysis of cell suspensions, the cell- 
pellets were resuspended in 200 ~1 IM. Pulse incubation was 
started by addition of 100 ~1 IM, containing 40 @i 
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FIG. 2. Analysis of newly synthesized desacetyl-aMSH (desAc- 
aMSIB and aMSH mesent in and released from intact neurointer- 
mediate lobes and‘ isolated intermediate lobe melanotropes of 
Xenopus luevis. Neumintennediate lobes or the cell suspension 
were given a pulse incubation i  [*Hltryptophsn a d a 3.5 hr chase 
incubation i medium containing L-tryptophan. Lobe extracts, cell 
extracts, and chase incubation media were then submitted to HPLC. 
The HPLC elution gradient is identical to that given in Fig. 1. Tissue 
and cell analyses are given in the upper profiles; analyses ofincuba- 
tion media re given in the lower p&lea. Tryptophan labeled prod- 
uct II is desacetyl-crMSH, product IV is aMSH and product I repre- 
sents the co-eluting peptides aMSH and /3MSH. 
[SH]lysine. Cells were subsequently centrifuged (10 mitt, 200 
g, 22°C) and the pellet resuspended for chase-incubation i  
500 ~1 IM with Llysine (2 n&l). Following this incubation 
cells were centrifuged, resuspended in500 ~10.1 N HCl and 
homogenized. Cell debris was removed by centrifugation (10 
min, 10,000 g, 4°C) and the supematant was submitted to 
HPLC. Chase medium was acidified with 20 ~1 1 N HCl 
before submission to HPLC. All incubation times are given 
in the fm legends. 
A similar experiment to that described above was con- 
ducted with 40 j&i [sHltryptophan (52 Ci/mmol, Amersham) 
as label. In this experiment each HPLC fraction was divided; 
part was used for analysis of radioactive peptides and part 
was submitted to radioimmunoassay for analysis of &lSH 
related peptides. 
HPLC Analysis of Radioactive Peptides 
Peptides were separated on a sperisorb 10 ODS column 
(Chrompack, Middelburg, the Netherlands). The primary 
solvent was 0.5 M formic acid/O.14 M pyridine, pH 3.0 (A) 
and elution was accomplished with a gradient of n-propanol 
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(B). The elution profile is indicated in Fii. 1. Fractions of 0.5 
min were collected, 4 ml of scintillation fluid (Packard 199) 
were added for subsequent determination of radioactivity in 
a liquid scintillation counter. 
Radioimmunoassay of aMSH 
The C-terminal directed antiserum to aMSH was 
produced and characterized by Vaudry et al. [27]. It has 
equal reactivity to (uMSH and desacetyl_aMSH. Bound and 
unbound MSH were separated by precipitation with poly- 
ethyleneglycol(7.5%). Sensitivity threshold of the assay is 5 
PB* 
Superfusion of Isolated Melanotropes 
Cells were suspended in a small volume of incubation 
medium and loaded in a 50 ~1 superfusion chamber with a 
millipore 0.45 pm filter (type HA) at the outlet to support a 
layer of biogel P2 (Biomd). Following loading the chamber 
was fllled with biogel. Medium was pumped with a peristaltic 
pump at a rate of 1.5 ml/hr and 7.5 min fractions were col- 
lected in 100 ~1 ice-cold 0.1 N HCl. Fractions were stored at 
-20°C before submission to radioimmunoassay. After an 
equilibration period of approximately 1 hr the effect of 
calcium-free medium with 0.5 M EGTA, or high K+ (osmo- 
larity maintained by addition of NaCl) was established by 
giving 15 min pulses of the modified media. For comparative 
purposes the effect of high K+ on MSH release from intact 
neurointermediate lobe tissue was investigated. Lobes were 
placed in a 10 ~1 superfusion chamber and superfusion was 
performed as described earlier [28,29]. 
The effect of dopamine and/or GABA was investigated by 
giving 15 min pulses of these neurotransmitters to the super- 
fused melanotropes. In additional experiments he dopamine 
DZreceptor antagonist sulpiride (Delagrange), the GABAa 
agonists homotaurine (kindly provided by Dr. Maggi, Italy) 
and isoguvacine (Cambridge Research Biochemicals) and the 
GABAb agonist baclofen (Ciba Geigy) were used. 
RESULTS 
Analysis of Cell Suspension Viability 
Average yield of cells was 18,ooO per neurointermediate 
lobe. Microscopical analysis showed that the suspension 
consisted for the most part of individual cells with occasional 
cohesion of two or three cells. Percentage of cell death was 
estimated to be 1%. As judged from the anti-oxytocin 
cytochemical staining, the cell suspension was free of neural 
lobe fragments. The oxytocin positive material remained as 
intact tissue on top of the nylon filter. 
Radiolabeled lysine was a convenient label for our initial 
biosynthetic analysis because this amino acid is present in all 
PGMC-related peptides products of Xenopus melanotrqes 
[16,19]. Shown in Fig. 1 are the results ofpulse-chase analysis 
of intact neurointermediate lobe tissue and the cell suspen- 
sion. The HPLC resolved peptides have been characterized 
earlier [I93 to be: I, yMSH; II, desacetyl-aMSH; IV, co- 
eluting peptides (rMSH and a form of corticotropin-like in- 
termediate peptide (CLIP), designated CLIP I; V,. a second 
form of CLIP, designated CLIP II; VI, unidentifled; 
VII/VIII, peptides immunologically related to mammalian 
flendorphin and designated endorpbin-like peptides. These 
earlier studies failed to identify BMSH. Sequence determi- 
nation of Xenopus FOMC-cDNA has healed that /3MSH is 
a potential biosynthetic product of Xenopus neurointer- 
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FIG. 3. Analysis of immunoreactive MSH present in and released from intact 
neurointe~edi~e lobe and isoiated intermediate i&e melanotropes of Xrnopus 
farvis. Data is derived from the same ex~~ment as that shown in Fig. 2; a portion 
of each HPLC fraction was submitted to radioimmunoassay. Tissue and cell 
analyses are given in the upper profiles, media analyses in the lower profiles. The 
peak eluting between 10 and 11 minutes probably reflects a slight cross-reactivity 
of the antiserum to vMSHf@MSH. Insert: HPLC analysis of tissue extract from an 
unincubated neurointermediate lobe. 
mediate lobes [16], and indeed our subsequent analysis has 
shown that newly synthesized PMSH co-elutes with yMSH 
in a peak I (manuscript in preparation). Co-elution of two 
peptides may account for the relatively high CPM value 
associated with peak I. 
The HPLC profile of newly synthesized lysine labeled 
peptides produced by and released from cell suspensions is 
very similar to that displayed by intact tissue with the nota- 
ble exception of the relatively high contribution of product II 
(desacetyl-~MSH) to the ~cubatio~ medium of the cell sus- 
pension (Fig. 1). To examine the biosynthesis of aMSH this 
experiment was repeated with 13H]-tryptophan as label (the 
CLIP peptide co-eluting with ~YMSH lacks tryptophan). The 
major tissue form of the newly synthesized CXMSH related 
peptides is desacetyl-crMSH, although some aMSH is asso- 
ciated with the tissue (Fig. 2). The intact tissue secretes both 
desacetyl-ffMSH and cuMSH, but crMSH now makes a major 
cont~bution to the HPLC profile. For the cell suspension 
newly synthesized desacetyl-crMSH is both the major cellu- 
lar and secretory form of (uMSH related peptides. There is 
virtually no newly synthesized (YMSH present (Fig. 2). 
Analysis oflmmunoreactive EwMSH Related Peptides 
Desacetyl-arMSH was the major form of immunor~c~ve 
MSH associated with both tissue (Fig. 3, left) and isolated 
ceils (Fig. 3, right). Separate experiments (n=3) showed that 
the percentage of non-acetylated aMSH was 772 1.7% in in- 
tact tissue and 8823.0% in isolated melanotropes. 
HPLC analysis of immunoreactive MSWfrom incubation 
medium of intact tissue shows that desacetyl-acMSH and 
aMSH make an approximately equal contribution to the 
medium (Fig. 3, left). There is apparently a reduction of 
tissue stores of MSH during in vitro incubation, indicated by 
the fact that the amount of MSH in the tissue of the incu- 
bated lobe is only about 10% of that found in an unincubated 
neurointeimediate lobe (Fig. 3, insert). Relative to intact tis- 
sue, the cell suspension had a low level of immunoreactive 
MSH (Fig. 3, right). These cells released predominantly the 
non-acetylated form of arMSH {Fig. 3). 
MSH Release From &perfused Melanotropes 
Superfused melanotropes had a tendency to show a slop- 
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FIG. 4. The release of i~~o~act~ve MSH from superfused melanotropes of
Xenopus luevis. Superfusion fractions were submit&d to radioimmunoassay for 
aMSH. Short pulses (15 min) of Ca-free medinm (containing 0.5 mM EGTA), 
medium containing 60 mM K+, or a combination of the two treatments were given 
as indicated in the fmre. Insert: The effect of 60 mM K+ on the release of MSH 
from intact neurointermediate lobes. Black bar indicates those fractions where 
sulpiride (IO-+ M) was included in the superfusion medium. Resnlts are expressed 
as percent basal release (-SEM, n=4); 100% basal release was defined in each 
experiment as the average amount of MSH in the three fractions preceding the 
first pulse of K+ (indicated by open circles). 
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FIG. 5. The effect of dopamine and GABA on the release of im- 
munoreactive MSH from superfused melanntropes of Xenopus 
In&s. Results areexpressed as percent basal release f_eSEM, n=4). 
Gpen circks indicate those fractions used to determine IO@% basal 
release. Superfusion conditions are described in Fig. 4. 
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FIG. 6. J%%ct of dopamine and the dopamine D&receptor 
antagonist sulpiride on the release of immunoreactive MSH from 
supertirsed metitropes ofXenopus laevis. Superfusion conditions 
are described in Fig. 4. 
VERBURG-VAN KEMENADE, JENKS AND DRIESSEN 
baclofen lsog”“acl”e homotaunne 
1xNT5M 5~10-~M 1 x lo-% 
--- 
2 4 6 6 10 2 4 6 6 10 2 4 6 8 10 
superfusion fraction no 
FIG. 7. The effect of GABA receptor agonists on the release of 
immunoreactive MSH from superfused melanotropes of Xenopus 
laevis. Baclofen is a GABAb receptor agonist and isoguvacine and 
homotaurine are GABAa receptor agonists. Superfusion conditions 
are described in Fig. 4. Open circles indicate those fractions used to 
determine 100% basal level of release. 
ing base-line of MSH release (e.g., Fig. 1). Also, the rate of 
release of MSH could vary widely between different cell 
suspension preparations. The dtierences in absolute value 
of MSH released in different experiments precluded averag- 
ing of results and therefore, where we wished to combine 
results from more than one experiment, they are expressed 
as a percentage of the basal rate of release (e.g., Fig. 5). In 
this case the average level of MSH in the three superfusion 
fractions immediately preceding the pulse of secretagogue 
was defined as 100% basal release for each experiment, and 
within each experiment all MSH values in superfusion frac- 
tions were then expressed relative to this basal value. 
The rate of release of (rMSH from superfused cells was 
reduced by giving a short pulse of Ca*+-free medium (Fig. 4). 
A pulse with medium containing 60 mM KC resulted in a 
dramatic increase in the amount of MSH found in the super- 
fusion fractions. This contrasts sharply with the response of 
intact tissue to 60 mM K+ (Fig. 4, insert), where the amount 
of MSH in the superfusion fractions decreases. Sulpiride had 
no effect on this K+ induced inhibition of MSH release. 
Both dopamine and GABA caused a clear reduction if the 
amount of MSH released to the superfusion medium (Fig. 5). 
The dopamine induced inhibition was very prolonged (Fig. 
6), but could be reversed by sulpiride, a dopamine D2- 
receptor agonist. Both the GABAb receptor agonist baclofen 
and the GABAa receptor agonists isoguvacine and 
homotaurine inhibited MSH secretion from superfused 
melanotropes (Fig. 7). 
DISCUSSION 
The results of our biosynthetic studies indicate that the 
cell suspension constitutes a viable population of melano- 
tropes. The only impairment we could detect was their in- 
ability to acetylate desacetyl-cuMSH to form aMSH. This 
observation is interesting in that it has been shown that 
acetylation of MSH in the pars intermedia of Xenopus laevis 
is associated with the secretory process [18]. The failure ot 
isolated cells to acetylate MSH may reflect the close asso- 
ciation of this event with exocytosis. Possibly. the acetyla- 
tion system is sensitive to minor perturbations of membrane 
structure or alterations in ionic environment. Another 
possible reason for the inability of isolated melanotropes to 
acetylate desacetyl-aMSH would be that the isolated 
melanotropes lack a physiological signal, which is necessary 
for the onset of the acetylation process. In separate experi- 
ments we have found that the degree of acetylation is prob- 
ably regulated according to the background color to which 
the animal is adapted. The secretion-associated acetylation 
of intact tissue is reflected in the present results by the en- 
hanced contribution of both newly synthesized (YMSH and 
immunoreactive cllMSH to the HPLC profile of incubation 
media relative to their contribution to the corresponding tis- 
sue profiles. The results indicate that while a small amount of 
intracellular acetylation is occurring, the non-acetylated 
peptide remains the major newly synthesized and im- 
munoreactive tissue form of (YMSH. In contrast, pulse-chase 
analysis with rat and mouse intermediate lobe tissue or ceils 
show that desacetyl-cYMSH is acetylated immediately follow- 
ing its biosynthesis [4, 5, 8, 1 I, IS]: not surprisingly, 
radioimmunoassay analysis of neurointermediate lobes of 
these species show that desacetyl-cYMSH makes only a very 
minor contribution of acetylated forms of this peptide [2. 6. 
11, 12, 221. Goldman and Loh [7] have recently suggested 
that the major route for acetylation of MSH in the inter- 
mediate lobe ofXPnopus lawis is comparable to the situation 
in mammals. In our opinion, the fact that desacetyl-aMSH is 
the major intracellular form of MSH in Xenoprc.5 makes such 
a comparison untenable. 
As expected for a secretory process, the release of im- 
munoreactive MSH from superfused melanotropes was 
found to be Ca”-dependent. The finding that high K + in the 
superfusion medium leads to a stimulation of the release of 
MSH was to be expected in that K’ depolarizes cell mem- 
branes. More interesting is the response of intact tissue to 
high K+, namely a complete inhibition of the secretion proc- 
ess. In that intact neurointermediate lobe tissue is rich in 
nerve terminals [3, 9, 20, 24, 25, 291, a good assumption is 
that high K+ induces secretion of a factor or factors from 
these terminals which subsequently inhibit MSH secretion 
from the melanotrope. Indeed, we have found that high K’ 
stimulates release of both dopamine and GABA from nerve 
terminals within the neurointermediate lobe tissue (unpub- 
lished observation). In view of the presence of at least these 
two inhibitory neurotransmitter systems within this tissue, it 
is not surprising that the dopamine receptor antagonist sul- 
piride failed to antagonize the K* induced inhibition of 
MSH-secretion. An important conclusion we can draw from 
the results with high K+ is that the isolated melanotropes 
appear to be free of any interfering nerve terminals. There- 
fore, in our subsequent studies with these cells we consider 
that any effect of secretagogues on release of MSH from the 
superfused melanotropes is due to a direct action of the sec- 
retagogues on the melanotropes themselves. 
Dopamine is an important MSH-inhibiting factor in both 
mammals and sub-mammalian species [I]. For Xr)noprrs 
luevis it has been shown that this neurotransmitter is ex- 
tremely potent in inhibiting release of both MSH [10,14] and 
other POMC-related peptides [ 13,171. All these studies have 
been conducted with intact neurointermediate lobe tissue. 
The present results establish that, in inducing inhibition of 
MSH release, dopamine acts directly on the melanotrope 
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cell. The Oberon that sops, a specific I.32 receptor 
an&go&t, could terse the dopamine ~~~‘~~tion 
indicates that Xenopus mehotrops possess dopamine re- 
ceptors of the D2 type. 
There are ncent indications that the neurotransmitter 
GABA may also be of general importance as an MSH sec- 
retagogue. A GABAergic f&r network has been fonnd 
throu&out the Pars intermedist of both the rat [21,31] and 
toad Xe~~ff~ h&s [29] and GABA has been shown to af- 
fect secretion of MSH in these species [26,29]. The response 
of Xenopus ne~~~~ia~ lobes to exogenous GAJ3A is 
a very rapid ~bition of secretion of ~uno~ve WSH 
1291. Subs~~nt receptor c~te~~on has shown that 
the Xenopuf neu~~te~a~ lobe tissue contains both 
GABAa and GABAb receptors. Activation of either of these 
receptors induces ~hibi~on of in vitro MSH secreti~r~ 
1301. It is apparent from the present results that the Xe~~~~ 
Iaevis mhmtmpe cell itself possesses both the GABAa and 
the GABAb receptor. Receptur i~oa at the music- 
tural level will have to resolve whether ~~adent 
GABAergic neuronal systems exist to independently utilize 
these two receptor mechanisms. 
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